What is the clinical evidence from this study?

Study design: Review. Population: Depression and Metabolic Syndrome (n=2816). Intervention: Antidepressants vs. No antidepressants or healthy controls. Primary outcome: Metabolic Syndrome (MetS).

November 28, 2018Open Access

Increased Risk of Metabolic Syndrome in Antidepressants Users: A Mini Review

Key Result

Antidepressants do not appear clearly associated with metabolic syndrome overall, except for H1-receptor high-affinity antidepressants which are associated with a higher prevalence of the condition.

Structured PICO

Does antidepressant use increase the risk of metabolic syndrome in patients with depressive symptoms?

Population

Patients with depressive symptoms or psychiatric disorders (data extracted from 8 studies)

Intervention

Antidepressants

Outcome

Occurrence of metabolic syndrome (MetS)

Antidepressant use, particularly those with high H1-receptor affinity, may be associated with an increased risk of developing metabolic syndrome in patients with depressive symptoms.

Limitations

Limited to publications in English language available in the MEDLINE database
The choice of a simple single search query might have caused the inclusion of a limited number of articles
Absence of reliable and detailed trial data reported in the studies included in the review

Abstract

Mounting evidence has shown that the risk of metabolic syndrome (MetS) is substantially overlapping in the diagnostic subgroups of psychiatric disorders. While it is widely acknowledged that patients receiving antipsychotic medications are at higher risk of MetS than antipsychotic-naive ones, the association between antidepressants and MetS is still debated. The goal of our mini review was to analyse the relationship among depressive symptoms, antidepressant use and the occurrence of MetS. Adhering to PRISMA guidelines, we searched MEDLINE, reference lists and journals, using the following search string: ((("Mental Disorders"Mesh) AND "Metabolic Syndrome"Mesh) AND "Antidepressive Agents"Mesh), and retrieved 36 records. Two reviewers independently assessed records and the mini review eventually included the data extracted from 8 studies. The Newcastle-Ottawa Scale was used to assess the quality of the selected studies. Overall, the results of the mini review seem to support the association among depressive symptoms, antidepressants therapy and MetS. Except for H1-R high-affinity ones, the relationship between antidepressants and MetS still needs to be clarified. Considering the widespread prescription of antidepressants, both on behalf of psychiatrists and primary care physicians, further research on this topic is recommended.

KI fragen

Bookmark

View Full Paper

KI fragen

Bookmark

View Full Paper

Cite This Study

Gramaglia et al. (Wed,) conducted a review in Depression and Metabolic Syndrome (n=2,816). Antidepressants vs. No antidepressants or healthy controls was evaluated on Metabolic Syndrome (MetS). Antidepressants do not appear clearly associated with metabolic syndrome overall, except for H1-receptor high-affinity antidepressants which are associated with a higher prevalence of the condition.

synapsesocial.com/papers/6a11137b076612a7a7169f73 https://doi.org/https://doi.org/10.3389/fpsyt.2018.00621

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: